Abstract
Soluble and phagocytic stimuli released PAF-acether from PMN leucocytes, as determined by chromatography and bioassay by platelet aggregation. The same material caused aggregation of human and rabbit PMN leucocytesin vitro which was inhibited by ETYA and PGI2. PGI2 also inhibited PAF-acether release by PMN leucocytes and,in vivo, PGI2 abolished not only PAF-acether-induced, but also immune complex or C5a-induced thrombocytopenia and neutropenia in rabbits. These data suggest that PAF-acether may be involved in activation of both platelets and PMN leucocytesin vivo.
Similar content being viewed by others
References
G. Camussi, C. Tetta, F. Bussolino, F. Cappio, R. Coda, C. Masera andG. Segoloni,Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation, Int. Archs Allergy appl. Immun.64, 25–41 (1981).
H. Movat, T. Uriuhara, N. Taichman, R. Rovsell andJ.F. Mustard,The role of PMN-leukocyte lysosomes in tissue injury, inflammation and hypersensitivity, Immunology14, 637–647 (1968).
P.R. Craddock, D. Hammerschmidt, J. White, A. Dalmasso andH. Jacob,Complement (C5a) induced granulocyte aggregation in vitro. Clin. Invest.60, 260–264 (1977).
J.T. O'Flaherty, S. Showell, L. Becker andP. Ward,Neutrophil aggregation and degranulation. Effect of arachidonic acid. Am. J. Pathol.95, 433–444 (1979).
J.T. O'Flaherty, S. Showell, L. Becker andP. Ward,Neutrophil aggregation: effect of the time and sequence of addition of Ca, Mg and chemotactic factor, J. Reticuloendoth. Soc.25, 29–38 (1979).
G. Camussi, C. Tetta, F. Bussolino, F. Cappio, R. Coda, C. Masera andG. Segoloni,Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. I. C5a anaphylatoxin, neutrophil cationic proteins and their cleavage fragments, Int. Archs Allergy appl. Immun.62, 1–15 (1980).
G. Camussi, M. Aglietta, R. Coda, F. Bussolino, W. Piacibello andC. Tetta,Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils, Immunology42, 191–199 (1981).
J. Lynch, G. Lotner, S. Betz andP.M. Henson,The release of a platelet-activating factor by stimulated rabbit neutrophils, J. Immunol.123, 1219–1226 (1979).
C. Demopoulos, R. Pinckard andD. Hanahan,Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators) J. Biol. Chem.254, 9355–9358 (1979).
J. Benveniste, M. Ténce, J. Bidault, C. Boullet andJ. Polonsky,Semi-synthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analog de la lyso-phosphatidylcholine. C.R. Acad. Sci. Paris D289, 1036–1040 (1979).
J. Godfroid, F. Heymans, E. Michel, C. Redeuilh, E. Steiner andJ. Benveniste,Platelet activating factor (PAF-acether): total synthesis of 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine, FEBS Lett.116, 161–164 (1980).
D. Hanahan, C. Demopoulos, J. Liehr andR. Pinckard,Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine, J. Biol. Chem.255, 5514–5516 (1980).
P.M. Henson,Activation of rabbit platelets by platelet-activating factor derived from IgE sensitized basophils, J. Clin. Invest.60, 481–490 (1977).
J.P. Cazenave, J. Benveniste andJ.F. Mustard,Aggregation of rabbit platelets by platelet activating factor is independent of the release reaction and arachidonate pathway and inhibited by membrane active drugs, Lab. Invest.41, 275–285 (1979).
L. McManus, D. Hanahan, C. Demopulos, andR. Pinckard,Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit, J. Immunol.124, 2919–2924.
H. Chap, G. Mauco, M. Simon, J. Benveniste andL. Douste Blazy,Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated latelets, Nature289, 312–314 (1981).
R. Pinckard, R. Farr andD. Hanahan,Physicochemical and functional identity of rabbit platelet activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils, J. Immunol.123, 1847–1857 (1979).
W. Ford-Hutchinson, A. Bray, V. Doig, E. Shipley andJ. Smith,Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature286, 264–265 (1980).
J. Benveniste, J.P. LeCouedic, J. Polonsky andM. Ténce,Structural analysis of purified platelet-activating factor by lipases, Nature269, 170–171 (1977).
J. Shaw andP.M. Henson,The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets, Am. J. Pathol.98, 791–810 (1980).
G. Camussi, F. Bussolino, C. Tetta, R. Brusca andR. Ragni,The binding of platelet-activating factor (PAF) to polymorphonuclear neutrophils (PMN) as a trigger for the immune-induced PMN aggregation, Pan. Med.22, 1–5 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Camussi, G., Tetta, C., Segoloni, G. et al. Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: The inhibitory effect of prostacyclin (PGI2). Agents and Actions 11, 550–553 (1981). https://doi.org/10.1007/BF01978735
Issue Date:
DOI: https://doi.org/10.1007/BF01978735